Cargando…
Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities
Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency, increased gonadotropin level, and, most importantly, amenorrhea. With the development of regenerative medicine, human m...
Autores principales: | Fu, Yun-Xing, Ji, Jing, Shan, Fang, Li, Jialing, Hu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931610/ https://www.ncbi.nlm.nih.gov/pubmed/33658073 http://dx.doi.org/10.1186/s13287-021-02212-0 |
Ejemplares similares
-
Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
por: Huang, Yanjing, et al.
Publicado: (2022) -
Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
por: Huang, Yanjing, et al.
Publicado: (2022) -
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
por: He, Yantao, et al.
Publicado: (2018) -
Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure
por: Zhang, Lin, et al.
Publicado: (2022) -
Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure
por: Shi, Lan, et al.
Publicado: (2022)